Skip to main content

Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference

CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2024 Cantor Global Healthcare Conference, which takes place September 17-19, 2024, at the InterContinental Barclay Hotel in New York City. John Aballi, Exagen’s President and Chief Executive Officer and Jeff Black, Exagen’s Chief Financial Officer, will participate in a fireside chat on Wednesday, September 18th, at 9:45 AM ET.

About Exagen Inc.

Exagen is a leading provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision making with the goal of improving patients’ clinical outcomes. Exagen is located in San Diego County, California.

For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).

Contact:
Ryan Douglas
Exagen Inc.
ir@exagen.com
760.560.1525


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  219.66
+1.71 (0.78%)
AAPL  258.37
-0.08 (-0.03%)
AMD  233.76
+3.53 (1.53%)
BAC  51.57
+0.47 (0.91%)
GOOG  254.72
+2.19 (0.87%)
META  740.28
+6.87 (0.94%)
MSFT  522.09
+1.55 (0.30%)
NVDA  181.07
+0.79 (0.44%)
ORCL  277.09
+4.43 (1.62%)
TSLA  424.79
-14.18 (-3.23%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.